AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26854877
Drug: Removable partial
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Removable partial dentures or implant‐supported fixed partial dentures (treatment group)
Trial: 19641050
Drug: Colloid preload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid preload (500 mL of hydroxyethyl starch over 15-20 min before spinal anesthesia)
Trial: 12197862
Drug: Behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural therapy (coping skills training and cognitive therapy)
Trial: 12197862
Drug: Non-specific supportive
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-specific supportive therapy
Trial: 7846192
Drug: Oxazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (20 and 40 mg)
Trial: 2903659
Drug: Esmolol (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (n = 12), continuous intravenous infusion, titrated from 2 to 24 mg/min
Trial: 2903659
Drug: Propranolol (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (n = 11), oral, dose increased every 6 hours by 50 to 100%
Trial: 30982351
Drug: Wheat samples
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat samples (17 different samples, 670 g/kg of each wheat sample in diet)
Trial: 27547871
Drug: No steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroids after intraoperative bolus
Trial: 21767283
Drug: Amitriptyline (12.5-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (12.5-50 mg)
Trial: 1383618
Drug: Pinacidil (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil (25 mg up to 100 mg daily)
Trial: 1383618
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg up to 80 mg daily)
Trial: 3905561
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg D-penicillamine daily
Trial: 3905561
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg D-penicillamine daily
Trial: 3905561
Drug: D-penicillamine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (both doses)
Trial: 26073333
Drug: Drospirenone-only pill
RxNorm normalized name: drospirenone Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone-only pill
Trial: 26073333
Drug: Desogestrel-only pill
RxNorm normalized name: desogestrel Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel-only pill
Trial: 24360131
Drug: Cochlear implants
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implants
Trial: 15334389
Drug: Pramlintide (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramlintide (60 microg subcutaneous premeal injections 3 times daily for 5 days, IV infusion of 16 microg/h)
Trial: 15334389
Drug: Placebo (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous premeal injections 3 times daily for 5 days, IV infusion of placebo)
Trial: 12845247
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (22 g for 48 hours)
Trial: 11829830
Drug: Rhodiola compound
RxNorm normalized name: RHODIOLA ROSEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhodiola compound (RCO) 4 grams daily for 3-15 days after admission and 5-7 days post-operation
Trial: 1925418
Drug: S-adenosylmethionine 800
RxNorm normalized name: S-adenosylmethionine
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosylmethionine 800 mg orally daily for six weeks
Trial: 3925464
Drug: l-histidine 3g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-histidine 3g/day for 7 days
Trial: 25147574
Drug: Real auricular
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real auricular point acupressure (APA) treatment
Trial: 18485150
Drug: Single agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agent therapy
Trial: 16305291
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 500 mg twice/day for 14 days
Trial: 8873108
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine (0.429 mg/kg)
Trial: 8873108
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine (0.214, 0.286, 0.357, and 0.429 mg/kg)
Trial: 6506360
Drug: Short-term catheter
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term catheter treatment (1 day)
Trial: 6506360
Drug: Long-term catheter
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term catheter treatment (14 days)
Trial: 29393194
Drug: Vonoprazan-based triple
RxNorm normalized name: vonoprazan
DrugBank: Vonoprazan (DB11739)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Vonoprazan-based triple therapy
Trial: 26946726
Drug: Pidotimod 10
RxNorm normalized name: pidotimod
DrugBank: Pidotimod (DB11364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod 10 mL orally once a day for 90 days
Trial: 25253679
Drug: Willingness to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Willingness to attend a workshop on medication regimen adjustment during Ramadan
Trial: 9579498
Drug: Morphine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (bolus dose of 100 microg/kg, followed by continuous infusion of 30 microg x kg(‐1) x h(‐1))
Trial: 8624293
Drug: 1 X
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 X (COPP + ABVD) chemotherapy (CT-arm)
Trial: 8624293
Drug: No consolidation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No consolidation therapy
Trial: 799995
Drug: halcinonide-neomycin-amphotericin cream
RxNorm normalized name: halcinonide / neomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: halcinonide-neomycin-amphotericin cream
Trial: 799995
Drug: hydrocortisone-iodochlorhydroxyquin cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hydrocortisone-iodochlorhydroxyquin cream
Trial: 31102257
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg q4w
Trial: 31102257
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg q6w
Trial: 31102257
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg q2w
Trial: 26883438
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intravenous infusion of ponesimod over 3 hours
Trial: 26883438
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral administration of ponesimod
Trial: 24705568
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy and/or contingency management (12-week randomized controlled trial)
Trial: 18486273
Drug: Weekly vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly vinorelbine chemotherapy (30 mg/m² for 6 weeks)
Trial: 17728357
Drug: High-dose rhEPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rhEPO (48,000 IU)
Trial: 17728357
Drug: Low-dose rhEPO
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rhEPO (8000 IU)
Trial: 17728357
Drug: Drug-naïve Parkinson
RxNorm normalized name: rotigotine
DrugBank: Rotigotine (DB05271)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug-naïve Parkinson patients (48,000 IU)
Trial: 11589674
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (Andropatch 2.5 mg patches, 1-2 patches per day)
Trial: 9400916
Drug: Lispro human
RxNorm normalized name: INSULIN LISPRO HUMAN 100 UNIT/ML HUMALOG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro human insulin (2.0 mU kg(‐1) min(‐1))
Trial: 9400916
Drug: Human soluble
RxNorm normalized name: Recombinant human soluble insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human soluble insulin (HS) (2.0 mU kg(‐1) min(‐1))
Trial: 7950410
Drug: Hyperosmolar agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperosmolar agent (glucose solution)
Trial: 3298379
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg azelastine
Trial: 3298379
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg azelastine
Trial: 3298379
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg azelastine
Trial: 27768797
Drug: IOP-reducing therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IOP-reducing therapy
Trial: 24108409
Drug: vestipitant (GW597599)
RxNorm normalized name: Vestipitant
DrugBank: Vestipitant (DB11949)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vestipitant (GW597599) 15 mg
Trial: 24108409
Drug: alprazolam 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alprazolam 0.75 mg
Trial: 24108409
Drug: vofopitant (GR205171)
RxNorm normalized name: Vofopitant
DrugBank: Vofopitant (DB12436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vofopitant (GR205171) 25 mg
Trial: 22594907
Drug: Bisoprolol/hydrochlorothiazide 5/6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol/hydrochlorothiazide 5/6.25 mg (R)
Trial: 22594907
Drug: Amlodipine/valsartan 5/160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/valsartan 5/160 mg (E)
Trial: 17436336
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation T
Trial: 17436336
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation R
Trial: 15872125
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ondansetron plus placebo (group H-O)
Trial: 15872125
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ondansetron plus 8 mg dexamethasone (group H-OD)
Trial: 15872125
Drug: None (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: None (group L)
Trial: 12373420
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg delta(9)-THC
Trial: 12373420
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg delta(9)-THC
Trial: 2650578
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg tid orally)
Trial: 2650578
Drug: Pentoxifylline and
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline and Acenocoumarol (combined treatment)
Trial: 31116270
Drug: Adductor canal
RxNorm normalized name: Canalevia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adductor canal block (ACB) using 20 ml of 0.25% levobupivacaine (ACB-L group)
Trial: 31116270
Drug: Periarticular infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periarticular infiltration using 40 ml (0.125 mg) of levobupivacaine (PAI-L group)
Trial: 23244247
Drug: Rifaximin 400
RxNorm normalized name: Rifaximin 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin 400 mg/day for 7 days/month followed by Lactobacillus casei for 7 days
Trial: 23244247
Drug: Antibiotic followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic followed by short chain fructo-oligosaccharides
Trial: 9737127
Drug: Umbilical vein
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umbilical vein injection of 20 units of oxytocin diluted to 20 ml with normal saline
Trial: 9737127
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 20 ml
Trial: 8062355
Drug: Acetaminophen 400
RxNorm normalized name: acetaminophen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 400 mg-codeine 25 mg combination (ACC)
Trial: 8062355
Drug: Aspirin 1000
RxNorm normalized name: aspirin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 1000 mg (A)
Trial: 2522062
Drug: Intranasal leuprolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal leuprolide 1.6 mg/day
Trial: 2522062
Drug: Danazol 800
RxNorm normalized name: Danazol
DrugBank: Danazol (DB01406)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Danazol 800 mg/day
Trial: 30617950
Drug: Synbiotics (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics (15 g of prebiotics, 5 g of probiotic powder containing Lactobacillus acidophilus T16, Bifidobacterium bifidum BIA‐6, Bifidobacterium lactis BIA‐6, and Bifidobacterium longum LAF‐5)
Trial: 30617950
Drug: Probiotics (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (5 g probiotics with 15 g of maltodextrin as placebo)
Trial: 30634880
Drug: Local lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local lidocaine spray (LS)
Trial: 28899222
Drug: Sotagliflozin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotagliflozin (400 mg per day)
Trial: 24902822
Drug: Individual adolescent-focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual adolescent-focused therapy (AFT)
Trial: 22051208
Drug: Modafinil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200 mg, single oral dose)
Trial: 15349687
Drug: Tripterygium hypoglaucum
RxNorm normalized name: Tripterygium wilfordii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripterygium hypoglaucum hutch tablet
Trial: 11020002
Drug: alpha2b interferon
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha2b interferon (6 MU tiw) plus ribavirin (1000-1200 mg daily) for 12 months
Trial: 11020002
Drug: alpha2b interferon
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha2b interferon (6 MU tiw) plus ribavirin (1000-1200 mg daily) for 6 months
Trial: 11020002
Drug: alpha2b interferon
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha2b interferon (6 MU tiw) plus ribavirin (1000-1200 mg daily)
Trial: 7829282
Drug: Weekly group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly group therapy session in the aftercare clinic
Trial: 29533729
Drug: 6-mm dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-mm dental implants
Trial: 29533729
Drug: 10-mm dental
RxNorm normalized name: benzocaine
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-mm dental implants
Trial: 29533729
Drug: Implant survival
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant survival rates
Trial: 26222435
Drug: Crinone vaginal
RxNorm normalized name: Crinone Vaginal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone vaginal progesterone gel (90 mg/d)
Trial: 26222435
Drug: Intramuscularly injected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscularly injected progesterone (40 mg/d)
Trial: 23743437
Drug: Bimatoprost 0.03%
RxNorm normalized name: BIMATOPROST 0.03% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03% preservative-free ophthalmic solution
Trial: 23743437
Drug: Bimatoprost 0.03%
RxNorm normalized name: BIMATOPROST 0.03% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03% ophthalmic solution (Lumigan)
Trial: 20639714
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (40 mg/kg/day for 3 months)
Trial: 20639714
Drug: Routine treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatments for FTT (Control)
Trial: 17722305
Drug: Antivir (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antivir (test formulation)
Trial: 17722305
Drug: Retrovir (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrovir (reference formulation)
Trial: 12680737
Drug: Lorazepam (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (2.0 mg)
Trial: 11106311
Drug: Flunitrazepam (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (1.0 mg)
Trial: 18241756
Drug: Heparin-bonded expanded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft
Trial: 6336824
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen treatment (pure oxygen)
Trial: 6336824
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (10% oxygen and 90% nitrogen)
Trial: 23115621
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV vaccine (Gardasil™) - Dose 1
Trial: 12842242
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg once daily
Trial: 12842242
Drug: Eplerenone 100
RxNorm normalized name: eplerenone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 100 mg once daily
Trial: 12160194
Drug: Eplerenone 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 400 mg once daily
Trial: 21986283
Drug: Eplerenone 50
RxNorm normalized name: eplerenone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 50 mg twice daily
Trial: 12160194
Drug: Eplerenone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 200 mg twice daily
Trial: 12160194
Drug: Spironolactone 50
RxNorm normalized name: spironolactone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 50 mg twice daily
Trial: 10466981
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (ivermectin and albendazole)
Trial: 2090474
Drug: Maintenance Dose
RxNorm normalized name: Firmagon 80mg Powder for Injection Maintenance Dose Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance Dose (MD)
Trial: 2090474
Drug: Twice the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice the Maintenance Dose (MDx2)
Trial: 31165191
Drug: Burosumab 1
RxNorm normalized name: Burosumab 10 mg/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Burosumab 1 mg/kg every 4 weeks
Trial: 21134775
Drug: Linezolid (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (IV or oral)
Trial: 19136101
Drug: 1 injection
RxNorm normalized name: vitamin K1 Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 injection of bupivacaine and triamcinolone
Trial: 19136101
Drug: 2 injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 injections of bupivacaine and triamcinolone
Trial: 18978166
Drug: Muesli with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muesli with 4 g oat beta-glucan
Trial: 10465130
Drug: Cefepime monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime monotherapy
Trial: 10465130
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with trimethoprim/sulfamethoxazole plus amikacin (TMP/SMZ plus AMI)
Trial: 1697490
Drug: Cimetidine 1
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1 g/day for 4 weeks
Trial: 1697490
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 1 g/day for 4 weeks
Trial: 1107506
Drug: 0.1 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/m2 of synthetic luteinizing hormone‐releasing hormone
Trial: 21515226
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg lumiracoxib
Trial: 18070204
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 6% active complex antiageing cream
Trial: 18070204
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of all-trans retinoic acid (RA)
Trial: 18070204
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 2% active complex antiageing cream
Trial: 18070204
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of basic moisturizer